Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Variation in Ophthalmologist Use of Antivascular Endothelial Growth Factor Therapy Among Medicare Beneficiaries

Variation in Ophthalmologist Use of Antivascular Endothelial Growth Factor Therapy Among Medicare... This study compares the use of lower- vs higher-cost antivascular endothelial growth factor drugs prescribed for treatment of retinal vascular diseases in the Medicare population. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Variation in Ophthalmologist Use of Antivascular Endothelial Growth Factor Therapy Among Medicare Beneficiaries

Loading next page...
 
/lp/american-medical-association/variation-in-ophthalmologist-use-of-antivascular-endothelial-growth-Ujp3R9mIkU
Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2016.2051
pmid
27366859
Publisher site
See Article on Publisher Site

Abstract

This study compares the use of lower- vs higher-cost antivascular endothelial growth factor drugs prescribed for treatment of retinal vascular diseases in the Medicare population.

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Sep 30, 2016

References